Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BridgeBio Pharma (BBIO) Return on Invested Capital (2025)

Historic Return on Invested Capital for BridgeBio Pharma (BBIO) over the last 1 years, with Q3 2025 value amounting to 0.71%.

  • BridgeBio Pharma's Return on Invested Capital changed N/A to 0.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71%, marking a year-over-year change of. This contributed to the annual value of 0.57% for FY2024, which is N/A changed from last year.
  • Latest data reveals that BridgeBio Pharma reported Return on Invested Capital of 0.71% as of Q3 2025.
  • BridgeBio Pharma's 5-year Return on Invested Capital high stood at 0.71% for Q3 2025, and its period low was 0.38% during Q2 2025.